HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rao, P. S. Articles by Guinn, G. Search for Related Content PubMed PubMed Citation Articles by Rao, P. S. Articles by Guinn, G.

The Annals of Thoracic Surgery, Vol 47, 589-592, Copyright © 1989 by The Society of Thoracic Surgeons

ARTICLES

Anticoagulant therapy in children with prosthetic valves

PS Rao, L Solymar, MK Mardini, ME Fawzy and G Guinn
Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

The purpose of this study was to evaluate the effectiveness and complications of several types of anticoagulant therapy in children with prosthetic valves. During a 7-year period ending April 1985, 130 children aged 1 to 19 years underwent left-sided valve replacement. Operative mortality was 3%, 5%, and 9%, respectively, for aortic, mitral, and aortic and mitral valve replacement. Among the 123 survivors, 32 (26%) had had aortic, 71 (58%) had had mitral, and 20 (16%) had had aortic and mitral valve replacement. Follow-up ranged from 2 months to 8.2 years, a total of 544 patient-years. The survivors were divided into three groups based on anticoagulant treatment: warfarin sodium, aspirin plus dipyridamole, and no anticoagulants. Among the patients who had aortic valve replacement, thromboembolic complications developed in 2.5% (2.5/100 patient-years) of the aspirin plus dipyridamole group and 5% of the group given no anticoagulants. Only the warfarin group (4%) experienced bleeding complications. Among the patients having mitral valve replacement, thromboembolic complications developed in 4% of the warfarin group, 3% of the aspirin plus dipyridamole group, and 11% of the no anticoagulant group. In addition, 2% of patients in the warfarin group experienced severe bleeding. Two fatal cerebrovascular accidents occurred, both in the aspirin plus dipyridamole group. Patients who received a mitral heterograft were not prescribed any anticoagulant medications, and no thromboembolic complications developed. Among patients having double- valve replacement, complications developed in 5% of the warfarin group and 27% of the group given no anticoagulants.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF]

				M. Masuda, H. Kado, H. Tatewaki, Y. Shiokawa, and H. Yasui Late results after mitral valve replacement with bileaflet mechanical prosthesis in children: evaluation of prosthesis-patient mismatch Ann. Thorac. Surg., March 1, 2004; 77(3): 913 - 917. [Abstract] [Full Text] [PDF]

				P. Monagle, A. D. Michelson, E. Bovill, and M. Andrew Antithrombotic Therapy in Children Chest, January 1, 2001; 119(1_suppl): 344S - 370S. [Full Text] [PDF]

				T. Gunther, D. Mazzitelli, C. Schreiber, M. Wottke, S.-U. Paek, H. Meisner, and R. Lange Mitral-valve replacement in children under 6 years of age Eur. J. Cardiothorac. Surg., April 1, 2000; 17(4): 426 - 430. [Abstract] [Full Text] [PDF]

				W. Streif, M. Andrew, V. Marzinotto, P. Massicotte, A.K.C. Chan, J.A. Julian, and L. Mitchell Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients Blood, November 1, 1999; 94(9): 3007 - 3014. [Abstract] [Full Text] [PDF]

				L. A Durham III, S. E. desJardins, R. S. Mosca, and E. L. Bove Ross Procedure With Aortic Root Tailoring for Aortic Valve Replacement in the Pediatric Population Ann. Thorac. Surg., August 1, 1997; 64(2): 482 - 486. [Abstract] [Full Text]

				S. M. Bradley, R. M. Sade, F. A. Crawford Jr, and M. R. Stroud Anticoagulation in Children With Mechanical Valve Prostheses Ann. Thorac. Surg., July 1, 1997; 64(1): 30 - 34. [Abstract] [Full Text]

				F. M. Lupinetti, J. Warner, T. K. Jones, and S. P. Herndon Comparison of Human Tissues and Mechanical Prostheses for Aortic Valve Replacement in Children Circulation, July 1, 1997; 96(1): 321 - 325. [Abstract] [Full Text]

				B. Gometza and C. M. G. Duran Ball Valve (Smeloff-Cutter) Aortic Valve Replacement Without Anticoagulation Ann. Thorac. Surg., November 1, 1995; 60(5): 1312 - 1316. [Abstract] [Full Text]

				H. Pouleur and M. Buyse EFFECTS OF DIPYRIDAMOLE IN COMBINATION WITH ANTICOAGULANT THERAPY ON SURVIVAL AND THROMBOEMBOLIC EVENTS IN PATIENTS WITH PROSTHETIC HEART VALVESA meta-analysis of the randomized trials J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 463 - 472. [Abstract] [Full Text]

				M. Ibrahim, J. Cleland, H. O'Kane, D. Gladstone, C. Mullholland, and B. Craig St. Jude Medical prosthesis in children J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 52 - 56. [Abstract] [Full Text]